7URE image
Entry Detail
PDB ID:
7URE
EMDB ID:
Title:
Human PORCN in complex with palmitoleoylated WNT3A peptide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-04-21
Release Date:
2022-07-20
Method Details:
Experimental Method:
Resolution:
3.19 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Isoform 2 of Protein-serine O-palmitoleoyltransferase porcupine
Chain IDs:A
Chain Length:464
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Protein Wnt-3a
Chain IDs:D (auth: B)
Chain Length:22
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:2C11 heavy chain
Chain IDs:C (auth: H)
Chain Length:250
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:2C11 light chain
Chain IDs:B (auth: L)
Chain Length:234
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Mechanisms and inhibition of Porcupine-mediated Wnt acylation.
Nature 607 816 822 (2022)
PMID: 35831507 DOI: 10.1038/s41586-022-04952-2

Abstact

Wnt signalling is essential for regulation of embryonic development and adult tissue homeostasis1-3, and aberrant Wnt signalling is frequently associated with cancers4. Wnt signalling requires palmitoleoylation on a hairpin 2 motif by the endoplasmic reticulum-resident membrane-bound O-acyltransferase Porcupine5-7 (PORCN). This modification is indispensable for Wnt binding to its receptor Frizzled, which triggers signalling8,9. Here we report four cryo-electron microscopy structures of human PORCN: the complex with the palmitoleoyl-coenzyme A (palmitoleoyl-CoA) substrate; the complex with the PORCN inhibitor LGK974, an anti-cancer drug currently in clinical trials10; the complex with LGK974 and WNT3A hairpin 2 (WNT3Ap); and the complex with a synthetic palmitoleoylated WNT3Ap analogue. The structures reveal that hairpin 2 of WNT3A, which is well conserved in all Wnt ligands, inserts into PORCN from the lumenal side, and the palmitoleoyl-CoA accesses the enzyme from the cytosolic side. The catalytic histidine triggers the transfer of the unsaturated palmitoleoyl group to the target serine on the Wnt hairpin 2, facilitated by the proximity of the two substrates. The inhibitor-bound structure shows that LGK974 occupies the palmitoleoyl-CoA binding site to prevent the reaction. Thus, this work provides a mechanism for Wnt acylation and advances the development of PORCN inhibitors for cancer treatment.

Legend

Protein

Chemical

Disease

Primary Citation of related structures